Navigation Links
BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
Date:9/22/2009

, and expectations related to clinical trials of PEG-PAL. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: the results of current and planned clinical trials related to PEG-PAL; the content and timing of decisions by the U.S. Food and Drug Administration and other regulatory agencies, particularly with respect to PEG-PAL, and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin(R), Naglazyme(R) and Kuvan(R) are registered trademarks of BioMarin Pharmaceutical Inc.

Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC.

    Contacts:

    Investors                       Media
    Eugenia Shen                    Susan Berg
    BioMarin Pharmaceutical Inc.    BioMarin Pharmaceutical Inc.
    (415) 506-6570                  (415) 506-6594


'/>"/>
SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
2. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces FDA Approval for Kuvan
5. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
6. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
7. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
8. Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
9. Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
10. Cytokine PharmaSciences Initiates Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
11. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015  Mobility Ventures LLC, an AM ... Bank of America (NYSE: BAC ) that ... financing of the revolutionary MV-1 - - the world,s ... ground up to provide safe and comfortable transportation for ... their loan to purchase a new MV-1 vehicle at ...
(Date:2/26/2015)... 2015 Every year many millions of donations ... disease.  Nevertheless, year after year doctors and the medical ... first test to determine the status of heart health ... not, even though that technology is over 100 years ... doctors know, (while most patients do not know) that ...
(Date:2/26/2015)... SAN JOSE, Calif. , Feb. 26, 2015 /PRNewswire/ ... Dickinson and Company) (NYSE: BDX ), ... Research, an innovative company focused on enabling high-resolution ... promoting their unique solutions for highly multiplexed cell ... The companies are promoting BD,s powerful BD FACS™ ...
Breaking Medicine Technology:Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3National Heart Health Month In February 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... recently enacted standard has replaced the Statement on Auditing ... Statement on Standards for Attestation Engagements No. 16 (SSAE ... service organizations to enforce a stronger set of controls ... http://photos.prnewswire.com/prnh/20080206/AQW030LOGO-b ) Rising Medical Solutions has taken ...
... FRANCISCO, Sept. 23, 2011 BASIS Science, Inc. today ... band due to launch later this year. The Basis ... health tracker with a web-based personal dashboard to help ... http://photos.prnewswire.com/prnh/20110923/LA74085 ) "With ongoing concerns about ...
Cached Medicine Technology:Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 2Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 3BASIS Reveals Details of Heart Rate and Health Tracker; Plans to Showcase Basis Band at Health 2.0 2
(Date:2/28/2015)... BC (PRWEB) February 28, 2015 Mew ... recently announced that they now provide business consulting services ... such as corporate tax planning and succession planning. Company ... entrusted to experienced professionals. On top of this, complex ... to handle corporate accounting. As a result, Mew and ...
(Date:2/28/2015)... Bethesda, MD (PRWEB) February 28, 2015 ... annual conference in person, the Mesothelioma Applied Research ... taking place on Tuesday, March 3, starting at 9:30 ... and requires no registration. The broadcast can be accessed ... visiting http://www.curemeso.org/symposium . , The Symposium is a ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Dr. ... Central Coast area residents, recently announced a special offer ... It’s a treatment option for new and established patients ... 2015 with a bright, white smile, Dr. Patel and ... of $299, marked down from the regular price of ...
(Date:2/28/2015)... 2015 How would you describe ... There are all kinds of different leaders, each ... of the advantages and applications of different leadership ... a new product this spring called The Leadership ... connection between personality type, leadership, and success. The ...
(Date:2/28/2015)... California (PRWEB) February 28, 2015 Developers of ... release of a new overlay plugin for Final Cut Pro ... Studios. , “FCPX Overlay Chromatic gives users total control over ... Christina Austin, CEO of Pixel Film Studios. “FCPX Overlay Chromatic ... an easy to use interface.” , FCPX Overlay Chromatic Grunge ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2
... premiere Health 2.0 social networking, doctor search and doctor review ... Kleinke to the board of advisors. "Having two of the ... strengthens our belief in what we are doing and also ... said Daniel Kogan, president and CEO of HealthWorldWeb . ...
... cells into damaged area helped restore blood flow, researchers ... a heart attack with the patients, own bone marrow ... may help reduce long-term complications, a new U.S. study ... angioplasty and stent placement after a heart attack. Within ...
... outside the home, the country also faces an epidemic of ... led to demands for nutritional labeling of restaurant foods. A ... examines the potential benefits of such labeling. , "Using only ... the levels of calories, saturated fat, trans fat, and sodium ...
... Today, the United States Department of Agriculture (USDA) ... the School Lunch Buy, a government sponsored feeding program."This ... available for the first time in several years, and ... 434,000 short tons, exceeding the previous record crop of ...
... 31 Dynatronics Corporation (Nasdaq: DYNT ) ... period extension with the SEC, giving the company until ... per share minimum bid rule."We are pleased that NASDAQ ... H. Cullimore Jr., chairman and president of Dynatronics. "This ...
... (IADR) announces Dr. Anthony Fauci, director, National Institute of ... of Health in Bethesda, Md., USA as 2009 IADR ... the 87th General Session & Exhibition in Miami, Florida, ... Fauci became director of NIAID, where he oversees an ...
Cached Medicine News:Health News:HealthWorldWeb Adds Michael Millenson and J.D. Kleinke to Board of Advisors 2Health News:Patient's Own Stem Cells Might Treat Heart Attack 2Health News:Full disclosure: People will make healthier choices if restaurants provide nutritional data 2Health News:USDA Adds Walnuts to Government Sponsored Meals 2Health News:USDA Adds Walnuts to Government Sponsored Meals 3Health News:NASDAQ Gives Dynatronics a Third Three-Month Extension for Minimum Bid Price Compliance 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: